參考資料

  • De Maio M, Rzany B. Botulinum Toxin in Aesthetic Medicine. Published by Springer- verlag, NY USA, 2007.
  • Kuwazuru et al. Skin wrinkling morphology changes suddenly in the early 30s. Skin Res Tech 2012; 18(4):495-503
  • Humber et al. In the shadow of the wrinkle: theories. J Cosmet Dermatol 2012; 11:72-78
  • Allergan data on file; Global Medical Affairs.
  • Medical Insight, Inc 2013. The Global Aesthetic Market Study: Accleration in Some Segments Offset by Slowdown in others.
  • noue et al. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 1996; 64(5):1589-94
  • Stotland MA et al. Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plast Reconsturct Surg 2007;120(5):1386-93.
  • 2013 Plastic Surgery Procedure Statistics: Top 5 Cosmetic Minimally-Invasive Procedures. American Society of Plastic Surgeons. Last accessed on 6 October 2014 on http://www.plasticsurgery.org/news/plastic-surgery-statistics/2013/top-five-cosmetic-minimally-invasive-procedures.html
  • Beer KR et al. Rapid onset of response and patient-repor ted outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines. J Drugs Dermatol 2011;10(1):39–44.
  • Botox® US Prescribing Information.
  • Carruthers et al. One-year, randomised, multicenter, tw-period study of the safety and efficacy of repeated treatments with botulinum toxin type A in patients with glabella lines. J Clin Res 2004; 7:1-20
  • Hornberger et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. Am Acad Derm 2004; 51(2) 274-286
  • Hund et al. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138(4):539-541.
  • Strutton et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241-248.
  • Lowe wt al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol. 2007;56(4):604-611.